BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31610409)

  • 1. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis.
    Sanchez AM; Cioffi R; Viganò P; Candiani M; Verde R; Piscitelli F; Di Marzo V; Garavaglia E; Panina-Bordignon P
    Reprod Sci; 2016 Aug; 23(8):1071-9. PubMed ID: 26887427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
    Smaga I; Bystrowska B; Gawliński D; Pomierny B; Stankowicz P; Filip M
    Neurotox Res; 2014 Aug; 26(2):190-206. PubMed ID: 24652522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol.
    Hanlon EC; Tasali E; Leproult R; Stuhr KL; Doncheck E; de Wit H; Hillard CJ; Van Cauter E
    Sleep; 2016 Mar; 39(3):653-64. PubMed ID: 26612385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol.
    Hanlon EC; Tasali E; Leproult R; Stuhr KL; Doncheck E; de Wit H; Hillard CJ; Van Cauter E
    J Clin Endocrinol Metab; 2015 Jan; 100(1):220-6. PubMed ID: 25368979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.
    Hill MN; Miller GE; Carrier EJ; Gorzalka BB; Hillard CJ
    Psychoneuroendocrinology; 2009 Sep; 34(8):1257-62. PubMed ID: 19394765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry.
    Lam PM; Marczylo TH; Konje JC
    Anal Bioanal Chem; 2010 Nov; 398(5):2089-97. PubMed ID: 20835819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
    Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
    Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method for simultaneous determination of N-arachidonoylethanolamine, N-oleoylethanolamine, N-palmitoylethanolamine and 2-arachidonoylglycerol in human cells.
    Ivanov I; Borchert P; Hinz B
    Anal Bioanal Chem; 2015 Feb; 407(6):1781-7. PubMed ID: 25519724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
    Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
    Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian Misalignment of the 24-hour Profile of Endocannabinoid 2-Arachidonoylglycerol (2-AG) in Obese Adults.
    Hanlon EC; Leproult R; Stuhr KL; Doncheck EM; Hillard CJ; Van Cauter E
    J Clin Endocrinol Metab; 2020 Mar; 105(3):792-802. PubMed ID: 31970413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible Anandamide and Palmitoylethanolamide involvement in human stroke.
    Naccarato M; Pizzuti D; Petrosino S; Simonetto M; Ferigo L; Grandi FC; Pizzolato G; Di Marzo V
    Lipids Health Dis; 2010 May; 9():47. PubMed ID: 20470384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder.
    Meyer JD; Crombie KM; Cook DB; Hillard CJ; Koltyn KF
    Med Sci Sports Exerc; 2019 Sep; 51(9):1909-1917. PubMed ID: 30973483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa.
    Monteleone AM; Di Marzo V; Aveta T; Piscitelli F; Dalle Grave R; Scognamiglio P; El Ghoch M; Calugi S; Monteleone P; Maj M
    Am J Clin Nutr; 2015 Feb; 101(2):262-9. PubMed ID: 25646322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses.
    Zimmermann T; Bartsch JC; Beer A; Lomazzo E; Guggenhuber S; Lange MD; Bindila L; Pape HC; Lutz B
    Neuropsychopharmacology; 2019 Jul; 44(8):1377-1388. PubMed ID: 30532004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training.
    Bystrowska B; Smaga I; Frankowska M; Filip M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():1-10. PubMed ID: 24334211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide.
    Jumpertz R; Wiesner T; Blüher M; Engeli S; Bátkai S; Wirtz H; Bosse-Henck A; Stumvoll M
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):591-5. PubMed ID: 20429051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms.
    Comai S; Nunez N; Atkin T; Ghabrash MF; Zakarian R; Fielding A; Saint-Laurent M; Low N; Sauber G; Ragazzi E; Hillard CJ; Gobbi G
    BMC Med; 2024 Jan; 22(1):33. PubMed ID: 38273283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.